Seashore M R, Walsh-Vockley C
Department of Human Genetics, Yale University School of Medicine, New Haven, Connecticut.
Yale J Biol Med. 1991 Jan-Feb;64(1):3-7.
Screening newborn infants for inherited disorders has been effective in preventing mental retardation, growth failure, and death from several metabolic disorders for more than two decades. Technical advances have provided more screening tools for both genetic and nongenetic conditions, and in the coming decades these techniques will be used not only to screen newborns but to assess genetic risks in entire populations. The financial, legal, and ethical issues which these activities raise must influence the development of public policies in order to reap the benefits promised. The conference published here was designed to address these issues for health care practitioners, health policy planners, and public health professionals.
二十多年来,对新生儿进行遗传性疾病筛查在预防智力迟钝、生长发育不良以及由多种代谢性疾病导致的死亡方面一直卓有成效。技术进步为遗传和非遗传疾病提供了更多的筛查工具,在未来几十年里,这些技术不仅将用于新生儿筛查,还将用于评估整个人口的遗传风险。这些活动引发的财务、法律和伦理问题必然会影响公共政策的制定,以便收获预期的益处。此处发表的会议旨在为医疗从业者、卫生政策规划者和公共卫生专业人员解决这些问题。